Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Paul Angulo, David E. Kleiner, Sanne Dam‐Larsen et al. · Gastroenterology · 2015 · 2.9K citations · Full text

Metabolic Associated Steatohepatitis, Fibrosis, Hepatology +14

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

David Adams, Alejandra González‐Duarte, William O’Riordan et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

TEAD mediates YAP-dependent gene induction and growth control

Bin Zhao, Xin Ye, Jindan Yu et al. · Genes & Development · 2008 · 2.5K citations · Full text

Hippo Pathway, Developmental Biology, Signaling Pathway +10

A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF^β-TRCP

Bin Zhao, Li Li, Karen Tumaneng et al. · Genes & Development · 2010 · 1.4K citations · Full text

A lipidomic analysis of nonalcoholic fatty liver disease

Rebecca Baillie, Michelle M. Wiest, Faridoddin Mirshahi et al. · Hepatology · 2007 · 1.3K citations · Full text